David Samuel, Fry Elizabeth J, López-Vales Rubèn
Center for Research in Neuroscience, The Research Institute of the McGill University Health Center, 1650 Cedar Avenue, Montreal, QC H3G 1A4, Canada.
Trends Neurosci. 2008 May;31(5):221-6. doi: 10.1016/j.tins.2008.02.002. Epub 2008 Apr 18.
The Nogo receptor (NgR), which was identified as a common receptor for three axon growth inhibitors associated with myelin, has been extensively characterized for its role in triggering growth cone collapse and arresting neurite/axon growth. Recent studies indicate that NgR is also expressed in nonneuronal cells and modulates macrophage responses during inflammation after peripheral nerve injury. In this article, we discuss the possibility that NgR might have wider effects on inflammation in a variety of neurological conditions ranging from central nervous system trauma to diseases such as multiple sclerosis or Alzheimer's disease.
诺戈受体(NgR)被确定为与髓磷脂相关的三种轴突生长抑制剂的共同受体,其在触发生长锥塌陷和阻止神经突/轴突生长方面的作用已得到广泛研究。最近的研究表明,NgR也在非神经元细胞中表达,并在周围神经损伤后的炎症过程中调节巨噬细胞反应。在本文中,我们探讨了NgR可能在从中枢神经系统创伤到诸如多发性硬化症或阿尔茨海默病等多种神经疾病的炎症中产生更广泛影响的可能性。